fashion -WSS

fashion

author：comprehensive 2025-09-28 02:31:20 - browse：4142

a person wearing blue dress conducts a finger prick test on another person in a home setting — coverage from STAT — Adobe

The last decade has seen billions of dollars flow into digital health companies that promise to improve outcomes for the 38 million Americans living with type 2 diabetes. Their products aren’t cheap, but in the long term, they pitch to health plans and employers that these digital tools will help cut health care costs by preventing serious complications like amputation and kidney failure.

A systematic review by the Peterson Health Technology Institute found, though, that digital tools used to manage diabetes with the help of finger-stick blood glucose readings don’t result in clinically meaningful improvements over standard care. As a result, they don’t reduce health care spending — they drive it up.

“Most of the solutions in this category do not deliver clinical benefits that justify their cost,” Caroline Pearson, executive director of the institute, told STAT. Despite finding that some populations may benefit, the report concludes that current evidence doesn’t support broader adoption for most products.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

WSS

Guidelines to prevent youth baseball injuries need more muscle

Lilly's Alzheimer's drug donanemab backed by FDA advisers

STAT Virtual Event: ASCO Recap, Live!

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Coercive sterilizations revealed by STAT prompt outrage

entertainment

fashion

focus

Supreme Court strikes down use of affirmative action

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

BioMarin wins approval for gene therapy to treat hemophilia A

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

How to save PrEP access — and even expand it

How faith leaders like me can help address America's obesity epidemic

Medicare proposal to cover medical devices draws a mixed reaction

My daughter's legacy lives on through her writing, phage therapy

Guidelines to prevent youth baseball injuries need more muscle

Walensky prepares to leave CDC — and Congress — behind

hotspot

Drug repurposing or repositioning? The language matters

5 takeaways from STAT's examination of Zynex Medical

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Cancer drug shortages should be causing more outrage

Report captures long Covid’s disabling effects and policy challenges

In age of alternative facts, a scholarly course on calling out crap

hotspot

hotspot

hotspot

knowledge